Top

Published in:

01-11-2018 | Review

Regulation of energy metabolism in the growth plate and osteoarthritic chondrocytes

Authors: Elena V. Tchetina, Galina A. Markova

Published in: Rheumatology International | Issue 11/2018

Abstract

Osteoarthritis (OA) is a chronic disorder associated mainly with pain, limited range of motion, stiffness, low-grade systemic inflammation, and articular cartilage destruction. Recent studies have demonstrated the involvement of chondrocyte differentiation (hypertrophy) as one of the mechanisms in cartilage degradation in OA. This implicates the involvement of principal changes in the regulation of cellular function associated with profound alterations in chondrocyte energy metabolism in the course of cartilage resorption. Therefore, this review describes the major energy-generating pathways and their regulatory molecules used by the growth plate chondrocytes during endochondral ossification and by articular chondrocytes in OA. These regulatory molecules facilitate either the glycolytic pathway of energy generation, which controls cell proliferation, or mitochondrial oxidative phosphorylation promoted by AMPK and sirtuins and responsible for tissue regeneration. Consideration of the disturbances in energy metabolic pathways associated with OA might provide an approach to disclose the primary causes of the disease’s development and progression. Medline/PubMed was searched for publications in English using key words: osteoarthritis, epiphyseal growth plate, articular cartilage, glycolysis, oxidative phosphorylation, and regulation of energy metabolism.

Poole AR, Guilak F, Abramson SB (2007) Etiopathogenesis of osteoarthritis. In: Moskowitz RW, Altman RD, Hochberg MC, Buckwalter JA, Goldberg VM (eds) Osteoarthritis: diagnosis and medical/surgical management, 4th edn. Williams & Wilkins, Philadelphia, pp 27–49

Little CB, Fosang AJ (2010) Is cartilage matrix breakdown an appropriate therapeutic target in osteoarthritis–insights from studies of aggrecan and collagen proteolysis? Curr Drug Targets 11:561–575PubMed

Bondeson J (2011) Are we moving in the right direction with osteoarthritis drug discovery? Expert Opin Ther Targets 15:1355–1368PubMed

Berenbaum F (2013) Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthr Cartil 21:16–21

Berenbaum F, Timothy M, Griffin, Ru Liu-Bryan (2017) Metabolic regulation of inflammation in osteoarthritis. Arthritis Rheumatol 69:9–21PubMedPubMedCentral

Yagi R, McBurney D, Laverty D, Weiner S, Horton WEJr (2005) Intrajoint comparison of gene expression patterns in human osteoarthritis suggest a change in chondrocyte phenotype. J Orthop Res 23:1128–1138PubMed

Kirsch T, Swoboda B, Nah H (2000) Activation of annexin II and V expression, terminal differentiation, mineralization and apoptosis in human osteoarthritic cartilage. Osteoarthr Cartil 8:294–302

Pullig O, Weseloh G, Ronneberger D, Käkönen S, Swoboda B (2000) Chondrocyte differentiation in human osteoarthritis: expression of osteocalcin in normal and osteoarthritic cartilage and bone. Calcif Tissue Int 67:230–240PubMed

Johnson K, Terkeltaub R (2004) Upregulated ank expression in osteoarthritis can promote both chondrocyte MMP-13 expression and calcification via chondrocyte extracellular PPi excess. Osteoarthr Cartil 12:321–335

10.

Robertson CM, Pennock AT, Harwood FL, Pomerleau AC, Allen RT, Amiel D (2006) Characterization of pro-apoptotic and matrix-degradative gene expression following induction of osteoarthritis in mature and aged rabbits. Osteoarthr Cartil 14:471–476

11.

Tchetina EV, Squires G, Poole AR (2005) Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions. J Rheumatol 32:876–886PubMed

12.

Zhang X, Crawford R, Xiao Y (2016) Inhibition of vascular endothelial growth factor with shRNA in chondrocytes ameliorates osteoarthritis. J Mol Med (Berl) 94:787–798

13.

Xu W, Xie Y, Wang Q, Wang X, Luo F, Zhou S, Wang Z, Huang J, Tan Q, Jin M, Qi H, Tang J, Chen L, Du X, Zhao C, Liang G, Chen L (2016) A novel fibroblast growth factor receptor 1 inhibitor protects against cartilage degradation in a murine model of osteoarthritis. Sci Rep 6:24042PubMedPubMedCentral

14.

Chen S, Fu P, Cong R, Wu H, Pei M (2015) Strategies to minimize hypertrophy in cartilage engineering and regeneration. Genes Dis 2:76–95PubMedPubMedCentral

15.

Agathocleous M, Harris WA (2013) Metabolism in physiological cell proliferation and differentiation. Trends Cell Biol 23:484–492PubMed

16.

Agathocleous M, Love NK, Randlett O, Harris JJ, Liu J, Murray AJ, Harris WA (2012) Metabolic differentiation in the embryonic retina. Nat Cell Biol 14:859–864PubMedPubMedCentral

17.

Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033PubMedPubMedCentral

18.

Komen JC, Thorburn DR (2014) Turn up the power–pharmacological activation of mitochondrial biogenesis in mouse models. Br J Pharmacol 171(8):1818–1836PubMedPubMedCentral

19.

Wilson DF (2013) Regulation of cellular metabolism: programming and maintaining metabolic homeostasis. J Appl Physiol (1985) 11 5:1583–1588

20.

Zoncu R, Efeyan A, Sabatini DM (2011) mTOR. From growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12:21–35PubMed

21.

Martin TD, Chen XW, Kaplan RE, Saltiel AR, Walker CL, Reiner DJ, Der CJ (2014) Ral and Rheb GTPase activating proteins integrate mTOR and GTPase signaling in aging, autophagy, and tumor cell invasion. Mol Cell 53:209–220PubMedPubMedCentral

22.

Marshall S (2006) Role of insulin, adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity, and cancer. Sci STKE 2006:re7PubMed

23.

Wang RH, Kim HS, Xiao C, Xu X, Gavrilova O, Deng CX (2011) Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance. J Clin Investig 121:4477–4490PubMedPubMedCentral

24.

Vanhaesebroeck B, Waterfield MD (1999) Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253:239–254PubMed

25.

Di Magno L, Manzi D, D’Amico D, Coni S, Macone A, Infante P, Di Marcotullio L, De Smaele E, Ferretti E, Screpanti I, Agostinelli E, Gulino A, Canettieri G (2014) Druggable glycolytic requirement for Hedgehog-dependent neuronal and medulloblastoma growth. Cell Cycle 13:3404–3413PubMedPubMedCentral

26.

Gonnissen A, Isebaert S, Haustermans K (2015) Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened. Oncotarget 6:13899–13913PubMedPubMedCentral

27.

Semenza GL (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148:399–408PubMedPubMedCentral

28.

Kim JW, Tchernyshyov I, Semenza GL, Dang CV (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3:177–185PubMed

29.

Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB, Gonzalez FJ, Semenza GL (2008) Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 283:10892–10903PubMedPubMedCentral

30.

Liu Y, Ma Z, Zhao C, Wang Y, Wu G, Xiao J, McClain CJ, Li X, Feng W (2014) HIF-1α and HIF-2α are critically involved in hypoxia-induced lipid accumulation in hepatocytes through reducing PGC-1α-mediated fatty acid β-oxidation. Toxicol Lett 226:117–123PubMed

31.

Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, Schumacker PT (2000) Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O₂ sensing. J Biol Chem 275:25130–25138PubMed

32.

Tello D, Balsa E, Acosta-Iborra B, Fuertes-Yebra E, Elorza A, Ordonez A, Corral-Escariz M, Soro I, López-Bernardo E, Perales-Clemente E, Martínez-Ruiz A, Enríquez JA, Aragonés J, Cadenas S, Landázuri MO (2011) Induction of the mitochondrial NDUFA4L2 protein by HIF-1alpha decreases oxygen consumption by inhibiting Complex I activity. Cell Metab 14:768–779PubMed

33.

Fukuda R, Zhang H, Kim JW, Shimoda L, Dang CV, Semenza GL (2007) HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129:111–122PubMed

34.

Conacci-Sorrell M, McFerrin L, Eisenman RN (2014) An overview of MYC and its interactome. Cold Spring Harb Perspect Med 4:a014357.5

35.

Shim H, Dolde C, Lewis BC, Wu CS, Dang G, Jungmann RA, Dalla-Favera R, Dang CV (1997) c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci USA 94:6658–6663PubMedPubMedCentral

36.

Zhou ZQ, Shung CY, Ota S, Akiyama H, Keene DR, Hurlin PJ (2011) Sequential and coordinated actions of c-Myc and N-Myc control appendicular skeletal development. PLoS One 6:e18795PubMedPubMedCentral

37.

Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, Turk BE, Shaw RJ (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30:214–226PubMedPubMedCentral

38.

June RK, Liu-Bryan R, Long F, Griffin TM (2016) Emerging role of metabolic signaling in synovial joint remodeling and osteoarthritis. J Orthop Res 34:2048–2058PubMedPubMedCentral

39.

Park S, Mori R, Shimokawa I (2013) Do sirtuins promote mammalian longevity? A critical review on its relevance to the longevity effect induced by calorie restriction. Molecules Cells 35:474–480PubMedPubMedCentral

40.

Houtkooper RH, Pirinen E, Auwerx J (2012) Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 13:225–238PubMedPubMedCentral

41.

Salminen A, Kaarniranta K (2012) AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing Res Rev 11:230–241PubMed

42.

Um JH, Park SJ, Kang H, Yang S, Foretz M, McBurney MW, Kim MK, Viollet B, Chung JH (2010) AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 59:554–563PubMed

43.

Maes C (2017) Signaling pathways effecting crosstalk between cartilage and adjacent tissues: seminars in cell and developmental biology: The biology and pathology of cartilage. Semin Cell Dev Biol 62:16–33PubMed

44.

Stambough JL, Brighton CT, Iannotti JP, Storey BT (1984) Characterization of growth plate mitochondria. J Orthop Res 2:235–246PubMed

45.

Shapiro IM, Srinivas V (2007) Metabolic consideration of epiphyseal growth: survival responses in a taxing environment. Bone 40:561–567PubMed

46.

Chen J, Long F (2014) mTORC1 signaling controls mammalian skeletal growth through stimulation of protein synthesis. Development 141:2848–2854PubMedPubMedCentral

47.

Yan B, Zhang Z, Jin D, Cai C, Jia C, Liu W, Wang T, Li S, Zhang H, Huang B, Lai P, Wang H, Liu A, Zeng C, Cai D, Jiang Y, Bai X (2016) mTORC1 regulates PTHrP to coordinate chondrocyte growth, proliferation and differentiation. Nat Commun 7:11151PubMedPubMedCentral

48.

Fujita T, Azuma Y, Fukuyama R, Hattori Y, Yoshida C, Koida M, Ogita K, Komori T (2004) Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J Cell Biol 166:85–95PubMedPubMedCentral

49.

Ford-Hutchinson AF, Ali Z, Lines SE, Hallgrímsson B, Boyd SK, Jirik FR (2007) Inactivation of Pten in osteo-chondroprogenitor cells leads to epiphyseal growth plate abnormalities and skeletal overgrowth. J Bone Miner Res 22:1245–1259PubMed

50.

Yang G, Sun Q, Teng Y, Li F, Weng T, Yang X (2008) PTEN deficiency causes dyschondroplasia in mice by enhanced hypoxia-inducible factor 1alpha signaling and endoplasmic reticulum stress. Development 135:3587–3597PubMed

51.

Araldi E, Schipani E (2010) Hypoxia, HIFs and bone development. Bone 47:190–196PubMedPubMedCentral

52.

Rajpurohit R, Koch CJ, Tao Z, Teixeira CM, Shapiro IM (1996) Adaptation of chondrocytes to low oxygen tension: relationship between hypoxia and cellular metabolism. J Cell Physiol 168:424–432PubMed

53.

Cheng S, Aghajanian P, Pourteymoor S, Alarcon C, Mohan S (2016) Prolyl hydroxylase domain-containing protein 2 (Phd2) regulates chondrocyte differentiation and secondary ossification in mice. Sci Rep 6:35748PubMedPubMedCentral

54.

Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, Johnson RS (2001) Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 15:2865–2876PubMedPubMedCentral

55.

Im S, Kim DW (2017) Nkx3.2 induces oxygen concentration-independent and lysosome-dependent degradation of HIF-1α to modulate hypoxic responses in chondrocytes. Cell Signal 36:127–138PubMed

56.

Tchetina E, Mwale F, Poole AR (2003) Distinct phases of coordinated early and late gene expression in growth plate chondrocytes in relationship to cell proliferation, matrix assembly, remodeling, and cell differentiation. J Bone Miner Res 18:844–851PubMed

57.

Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ (1996) Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273:613–622PubMed

58.

Phornphutkul C, Wu KY, Auyeung V, Chen Q, Gruppuso PA (2008) mTOR signaling contributes to chondrocyte differentiation. Dev Dyn 237:702–712PubMedPubMedCentral

59.

Stott NS, Chuong CM (1997) Dual action of sonic hedgehog on chondrocyte hypertrophy: retrovirus mediated ectopic sonic hedgehog expression in limb bud micromass culture induces novel cartilage nodules that are positive for alkaline phosphatase and type X collagen. J Cell Sci 110:2691–2701PubMed

60.

Tavella S, Biticchi R, Schito A, Minina E, Di Martino D, Pagano A, Vortkamp A, Horton WA, Cancedda R, Garofalo S (2004) Targeted expression of SHH affects chondrocyte differentiation, growth plate organization, and Sox9 expression. J Bone Miner Res 19:1678–1688PubMed

61.

Aizawa T, Kokubun S, Kawamata T, Tanaka Y, Roach HI (1999) c-Myc protein in the rabbit growth plate. Changes in immunolocalisation with age and possible roles from proliferation to apoptosis. J Bone Jt Surg Br 81:921–925

62.

Toury R, Wang Y, Hauchecorne M, Balmain N (1999) c-Myc and Mxi1 immunoreactivities in the calcifying areas of the epiphyseal-plate cartilage matrix of growing rats. Bone 24:555–563PubMed

63.

Piedra ME, Delgado MD, Ros MA, Leo´n J (2002) c-Myc overexpression increases cell size and impairs cartilage differentiation during chick limb development. Cell Growth Differ 13:185–193PubMed

64.

Bohensky J, Leshinsky S, Srinivas V, Shapiro IM (1982) Chondrocyte autophagy is stimulated by HIF-1 dependent AMPK activation and mTOR suppression. Pediatr Nephrol 25:633–642

65.

Shapiro IM, Golub EE, Kakuta S, Hazelgrove J, Havery J, Chance B, Frasca P (1982) Initiation of endochondral calcification is related to changes in the redox state of hypertrophic chondrocytes. Science 217:950–952PubMed

66.

Piao J, Tsuji K, Ochi H, Iwata M, Koga D, Okawa A, Morita S, Takeda S, Asou Y (2013) Sirt6 regulates postnatal growth plate differentiation and proliferation via Ihh signaling. Sci Rep 3:3022PubMedPubMedCentral

67.

Cooper KL, Oh S, Sung Y, Dasari RR, Kirschner MW, Tabin CJ (2013) Multiple phases of chondrocyte enlargement underlie differences in skeletal proportions. Nature 495:375–378PubMedPubMedCentral

68.

Wang F, Zhu Y (2011) Aquaporin-1: a potential membrane channel for facilitating the adaptability of rabbit nucleus pulposus cells to an extracellular matrix environment. J Orthop Sci 16:304–312PubMed

69.

Zhang Y, Vasheghani F, Li YH, Blati M, Simeone K, Fahmi H, Lussier B, Roughley P, Lagares D, Pelletier JP, Martel-Pelletier J, Kapoor M (2015) Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis. Ann Rheum Dis 74:1432–1440PubMed

70.

Pollesello P, de Bernard B, Grandolfo M, Paoletti S, Vittur F, Kvam BJ (1991) Energy state of chondrocytes assessed by 31P-NMR studies of preosseous cartilage. Biochem Biophys Res Commun 180:216–222PubMed

71.

Scott JL, Gabrielides C, Davidson RK, Swingler TE, Clark IM, Wallis GA, Boot-Handford RP, Kirkwood TB, Taylor RW, Young DA (2010) Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann Rheum Dis 69:1502–1510PubMed

72.

Blanco FJ, Rego I, Ruiz-Romero C (2011) The role of mitochondria in osteoarthritis. Nat Rev Rheumatol 7:161–169PubMed

73.

Yang X, Chen W, Zhao X, Chen L, Li W, Ran J, Wu L (2018) Pyruvate kinase M2 modulates the glycolysis of chondrocyte and extracellular matrix in osteoarthritis. DNA Cell Biol 37:271–277PubMed

74.

Liu-Bryan R, Terkeltaub R (2015) Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol 11:35–44PubMed

75.

Qu J, Lu D, Guo H, Miao W, Wu G, Zhou M (2016) PFKFB3 modulates glycolytic metabolism and alleviates endoplasmic reticulum stress in human osteoarthritis cartilage. Clin Exp Pharmacol Physiol 43:312–318PubMed

76.

Tchetina EV, Poole AR, Zaitseva EM, Sharapova EP, Kashevarova NG, Taskina EA, Alekseeva LI, Semyonova LA, Glukhova SI, Kuzin AN, Makarov MA, Makarov SA (2013) Differences in Mammalian target of rapamycin gene expression in the peripheral blood and articular cartilages of osteoarthritic patients and disease activity. Arthritis 2013:461486PubMedPubMedCentral

77.

Alvarez-Garcia O, Matsuzaki T, Olmer M, Plate L, Kelly JW, Lotz MK (2017) Regulated in development and DNA damage response 1 deficiency impairs autophagy and mitochondrial biogenesis in articular cartilage and increases the severity of experimental osteoarthritis. Arthritis Rheumatol 69:1418–1428PubMedPubMedCentral

78.

Vasheghani F, Zhang Y, Li YH, Blati M, Fahmi H, Lussier B, Roughley P, Lagares D, Endisha H, Saffar B, Lajeunesse D, Marshall WK, Rampersaud YR, Mahomed NN, Gandhi R, Pelletier JP, Martel-Pelletier J, Kapoor M (2015) PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage. Ann Rheum Dis 74:569–578PubMed

79.

Xue JF, Shi ZM, Zou J, Li XL (2017) Inhibition of PI3K/AKT/mTOR signaling pathway promotes autophagy of articular chondrocytes and attenuates inflammatory response in rats with osteoarthritis. Biomed Pharmacother 89:1252–1261PubMed

80.

Chang SF, Huang KC, Cheng CC, Su YP, Lee KC, Chen CN, Chang HI (2017) Glucose adsorption to chitosan membranes increases proliferation of human chondrocyte via mammalian target of rapamycin complex 1 and sterol regulatory element-binding protein-1 signaling. J Cell Physiol 232:2741–2749PubMed

81.

Chen J, Crawford R, Xiao Y (2013) Vertical inhibition of the PI3K/Akt/mTOR pathway for the treatment of osteoarthritis. J Cell Biochem 114:245–249PubMed

82.

Lin C, Shao Y, Zeng C, Zhao C, Fang H, Wang L, Pan J, Liu L, Qi W, Feng X, Qiu H, Zhang H, Chen Y, Wang H, Cai D, Xian CJ (2018) Blocking PI3K/AKT signaling inhibits bone sclerosis in subchondral bone and attenuates post-traumatic osteoarthritis. J Cell Physiol 233:6135–6147PubMed

83.

Li D, Wu Z, Duan Y, Hao D, Zhang X, Luo H, Chen B, Qiu G (2012) TNFα-mediated apoptosis in human osteoarthritic chondrocytes sensitized by PI3K-NF-κB inhibitor, not mTOR inhibitor. Rheumatol Int 32:2017–2022PubMed

84.

Rosa SC, Rufino AT, Judas F, Tenreiro C, Lopes MC, Mendes AF (2011) Expression and function of the insulin receptor in normal and osteoarthritic human chondrocytes: modulation of anabolic gene expression, glucose transport and GLUT-1 content by insulin. Osteoarthr Cartil 19:719–727

85.

Pfander D, Cramer T, Swoboda B (2005) Hypoxia and HIF-1alpha in osteoarthritis. Int Orthop 29:6–9PubMed

86.

Fernández-Torres J, Zamudio-Cuevas Y, Martínez-Nava GA, López-Reyes AG (2017) Hypoxia-inducible factors (HIFs) in the articular cartilage: a systematic review. Eur Rev Med Pharmacol Sci 21:2800–2810PubMed

87.

Ishizuka S, Sakai T, Hiraiwa H, Hamada T, Knudson W, Omachi T, Ono Y, Nakashima M, Matsukawa T, Oda T, Takamatsu A, Yamashita S, Ishiguro N (2016) Hypoxia-inducible factor-2α induces expression of type X collagen and matrix metalloproteinases 13 in osteoarthritic meniscal cells. Inflamm Res 65:439–448PubMed

88.

Rankin EB, Giaccia AJ, Schipani E (2011) A central role for hypoxic signaling in cartilage, bone, and hematopoiesis. Curr Osteoporos Rep 9:46–52PubMedPubMedCentral

89.

Qing L, Lei P, Liu H, Xie J, Wang L, Wen T, Hu Y (2014) Expression of hypoxia-inducible factor-1α in synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis. Exp Ther Med 13:63–68

90.

Chu H, Xu ZM, Yu H, Zhu KJ, Huang H (2013) Association between hypoxia-inducible factor-1a levels in serum and synovial fluid with the radiographic severity of knee osteoarthritis. Genet Mol Res 13:10529–10536

91.

Markway BD, Cho H, Johnstone B (2013) Hypoxia promotes redifferentiation and suppresses markers of hypertrophy and degeneration in both healthy and osteoarthritic chondrocytes. Arthritis Res Ther 15:R92PubMedPubMedCentral

92.

Gouttenoire J, Valcourt U, Ronzière MC, Aubert-Foucher E, Mallein-Gerin F, Herbage D (2004) Modulation of collagen synthesis in normal and osteoarthritic cartilage. Biorheology 41:535–542PubMed

93.

Zhou J, Wei X, Wei L (2014) Indian Hedgehog, a critical modulator in osteoarthritis, could be a potential therapeutic target for attenuating cartilage degeneration disease. Connect Tissue Res 55:257–261PubMed

94.

Li R, Cai L, Ding J, Hu CM, Wu TN, Hu XY (2015) Inhibition of hedgehog signal pathway by cyclopamine attenuates inflammation and articular cartilage damage in rats with adjuvant-induced arthritis. J Pharm Pharmacol 67:963–971PubMed

95.

Pelletier JP, Faure MP, DiBattista JA, Wilhelm S, Visco D, Martel-Pelletier J (1993) Coordinate synthesis of stromelysin, interleukin-1, and oncogene proteins in experimental osteoarthritis. An immunohistochemical study. Am J Pathol 142:95–105PubMedPubMedCentral

96.

Yatsugi N, Tsukazaki T, Osaki M, Koji T, Yamashita S, Shindo H (2000) Apoptosis of articular chondrocytes in rheumatoid arthritis and osteoarthritis: correlation of apoptosis with degree of cartilage destruction and expression of apoptosis-related proteins of p53 and c-myc. J Orthop Sci 5:150–156PubMed

97.

Zhou Y, Tao H, Li Y, Deng M, He B, Xia S, Zhang C, Liu S (2016) Berberine promotes proliferation of sodium nitroprusside-stimulated rat chondrocytes and osteoarthritic rat cartilage via Wnt/β-catenin pathway. Eur J Pharmacol 789:109–118PubMed

98.

Dvir-Ginzberg M, Steinmeyer J (2013) Towards elucidating the role of SirT1 in osteoarthritis. Front Biosci 18:343e55

99.

Gabay O, Oppenhiemer H, Meir H, Zaal K, Sanchez C, Dvir-Ginzberg M (2012) Increased apoptotic chondrocytes in articular cartilage from adult heterozygous SirT1 mice. Ann Rheum Dis 71:613–616PubMed

100.

Dvir-Ginzberg M, Gagarina V, Lee EJ, Hall DJ (2008) Regulation of cartilage-specific gene expression in human chondrocytes by SirT1 and nicotinamide phosphoribosyltransferase. J Biol Chem 283:36300e10

101.

Wu Y, Chen L, Wang Y, Li W, Lin Y, Yu D, Zhang L, Li F, Pan Z (2015) Overexpression of Sirtuin 6 suppresses cellular senescence and NF-κB mediated inflammatory responses in osteoarthritis development. Sci Rep 5:17602PubMedPubMedCentral

102.

Matsuzaki T, Matsushita T, Takayama K, Matsumoto T, Nishida K, Kuroda R, Kurosaka M (2014) Disruption of Sirt1 in chondrocytes causes accelerated progression of osteoarthritis under mechanical stress and during ageing in mice. Ann Rheum Dis 73:1397–1404PubMed

103.

Gabay O, Sanchez C, Dvir-Ginzberg M, Gaqarina V, Zaal KJ, Song Y, He XH, McBurney MW (2013) Sirt1 enzymatic activity is required for cartilage homeostasis in vivo. Arthritis Rheum 65:159–166PubMedPubMedCentral

104.

Moon MH, Jeong JK, Lee YJ, Seol JW, Jackson CJ, Park SY (2013) SIRT1, a class III histone deacetylase, regulates TNFα-induced inflammation in human chondrocytes. Osteoarthr Cartil 21:470–480

105.

Igarashi M, Sakamoto K, Nagaoka I (2017) Effect of glucosamine on expression of type II collagen, matrix metalloproteinase and sirtuin genes in a human chondrocyte cell line. Int J Mol Med 39:472–478PubMed

106.

Yang S, Ryu JH, Oh H, Jeon J, Kwak JS, Kim JH, Kim HA, Chun CH, Chun JS (2015) NAMPT (visfatin), a direct target of hypoxia-inducible factor-2α, is an essential catabolic regulator of osteoarthritis. Ann Rheum Dis 74:595–602PubMed

107.

Terauchi K, Kobayashi H, Yatabe K, Yui N, Fujiya H, Niki H, Musha H, Yudoh K (2016) The NAD-dependent deacetylase sirtuin-1 regulates the expression of osteogenic transcriptional activator runt-related transcription factor 2 (Runx2) and production of matrix metalloproteinase (MMP)-13 in chondrocytes in osteoarthritis. Int J Mol Sci 17:1019PubMedCentral

108.

Terkeltaub R, Yang B, Lotz M, Liu-Bryan R (2011) Chondrocyte AMP-activated protein kinase activity suppresses matrix degradation responses to proinflammatory cytokines interleukin-1beta and tumor necrosis factor alpha. Arthritis Rheum 63:1928–1937PubMedPubMedCentral

109.

Wang Y, Zhao X, Lotz M, Terkeltaub R, Liu-Bryan R (2015) Mitochondrial biogenesis is impaired in osteoarthritis chondrocytes but reversible via peroxisome proliferator-activated receptor gamma coactivator 1alpha. Arthritis Rheumatol 67:2141–2153PubMedPubMedCentral

110.

Zhou S, Lu W, Chen L, Ge Q, Chen D, Xu Z, Shi D, Dai J, Li J, Ju H, Cao Y, Qin J, Chen S, Teng H, Jiang Q (2017) AMPK deficiency in chondrocytes accelerated the progression of instability-induced and ageing-associated osteoarthritis in adult mice. Sci Rep 7:43245PubMedPubMedCentral

111.

Tchetina EV, Markova GA, Poole AR, Zukor DJ, Antoniou J, Makarov SA, Kuzin AN (2016) Deferoxamine suppresses collagen cleavage and protease, Cytokine, and COL10A1 expression and upregulates AMPK and Krebs cycle genes in human osteoarthritic cartilage. Int J Rheumatol 2016:6432867PubMedPubMedCentral

112.

Al-Khazraji BK, Appleton CT, Beier F, Birmingham TB, Shoemaker JK (2018) Osteoarthritis, cerebrovascular dysfunction and the common denominator of inflammation: a narrative review. Osteoarthr Cartil 26:462–470

113.

Attur M, Krasnokutsky S, Statnikov A, Samuels J, Li Z, Friese O, Graverand-Gastineau HL, Rybak MP, Kraus L, Jordan VB, Aliferis JM, Abramson CF SB (2015) Low-grade inflammation in symptomatic knee osteoarthritis: prognostic value of inflammatory plasma lipids and peripheral blood leukocyte biomarkers. Arthritis Rheumatol 67:2905–2915PubMedPubMedCentral

114.

Ponchel F, Burska AN, Hensor EM, Raja R, Campbell M, Emery P, Conaghan PG (2015) Changes in peripheral blood immune cell composition in osteoarthritis. Osteoarthr Cartil 23:1870–1878

115.

Kyostio-Moore S, Nambiar B, Hutto E, Ewing PJ, Piraino S, Berthelette P, Sookdeo C, Matthews G, Armentano D (2011) STR/ort mice, a model for spontaneous osteoarthritis, exhibit elevated levels of both local and systemic inflammatory markers. Comp Med 61:346–355PubMedPubMedCentral

116.

Attur M, Belitskaya-Lévy I, Oh C, Krasnokutsky S, Greenberg J, Samuels J, Smiles S, Lee S, Patel J, Al-Mussawir H, McDaniel G, Kraus VB, Abramson SB (2011) Increased interleukin-1β gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis. Arthritis Rheum 63:1908–1917PubMedPubMedCentral

117.

Sowers MR, Karvonen-Gutierrez CA (2010) The evolving role of obesity in knee osteoarthritis. Curr Opin Rheumatol 22:533–537PubMedPubMedCentral

118.

Gegout PP, Francin PJ, Mainard D, Presle N (2010) Adipokines in osteoarthritis: friends or foes of cartilage homeostasis? Jt Bone Spine 75:669–671

119.

Gabay O, Hall DJ, Berenbaum F, Henrotin Y, Sanchez C (2008) Osteoarthritis and obesity: experimental models. Jt Bone Spine 75:675–679

120.

Laiguillon MC, Houard X, Bougault C, Gosset M, Nourissat G, Sautet A, Jacques C, Berenbaum F, Sellam J (2014) Expression and function of visfatin (Nampt), an adipokine-enzyme involved in inflammatory pathways of osteoarthritis. Arthritis Res Ther 16(1):R38PubMedPubMedCentral

121.

Chen WP, Bao JP, Feng J, Hu PF, Shi ZL, Wu LD (2010) Increased serum concentrations of visfatin and its production by different joint tissues in patients with osteoarthritis. Clin Chem Lab Med 48:1141–1145PubMed

122.

Calvet J, Orellana C, Gratacós J, Berenguer-Llergo A, Caixàs A, Chillarón JJ, Pedro-Botet J, García-Manrique M, Navarro N, Larrosa M (2016) Synovial fluid adipokines are associated with clinical severity in knee osteoarthritis: a cross-sectional study in female patients with joint effusion. Arthritis Res Ther 18(1):207PubMedPubMedCentral

123.

Duan Y, Hao D, Li M, Wu Z, Li D, Yang X, Qiu G (2012) Increased synovial fluid visfatin is positively linked to cartilage degradation biomarkers in osteoarthritis. Rheumatol Int 32:985–990PubMed

124.

Fioravanti A, Cheleschi S, De Palma A, Addimanda O, Mancarella L, Pignotti E, Pulsatelli L, Galeazzi M, Meliconi R (2018) Can adipokines serum levels be used as biomarkers of hand osteoarthritis? Biomarkers 23:265–270PubMed

125.

McNulty AL, Miller MR, O’Connor SK, Guilak F (2011) The effects of adipokines on cartilage and meniscus catabolism. Connect Tissue Res 52:523–533PubMedPubMedCentral

126.

Poonpet T, Honsawek S (2014) Adipokines: Biomarkers for osteoarthritis? World J Orthop 5:319–327PubMedPubMedCentral

127.

Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, Chi H (2011) HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 208:1367–1376PubMedPubMedCentral

128.

Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, Ziegler SF, Littman DR (2008) TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgamma function. Nature 453:236–240PubMedPubMedCentral

129.

Straub RH, Cutolo M, Buttgereit F, Pongratz G (2010) Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J Intern Med 267:543–560PubMed

Title: Regulation of energy metabolism in the growth plate and osteoarthritic chondrocytes
Authors: Elena V. Tchetina
Galina A. Markova
Publication date: 01-11-2018
Publisher: Springer Berlin Heidelberg
Published in: Rheumatology International / Issue 11/2018
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-018-4103-4

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Regulation of energy metabolism in the growth plate and osteoarthritic chondrocytes

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2018

Proton pump inhibitors’ use and risk of hip fracture: a systematic review and meta-analysis

Patterns of the initiation of disease-modifying antirheumatic drugs in incident rheumatoid arthritis: a German perspective based on nationwide ambulatory drug prescription data

Associations between fatigue and physical capacity in people moderately affected by rheumatoid arthritis

Non-pharmacological options for managing chronic musculoskeletal pain in children with pediatric rheumatic disease: a systematic review

Observational study and brief analysis of diagnostic criteria in relapsing polychondritis

Denosumab in the treatment of glucocorticoid-induced osteoporosis

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page